27th April 2020
Pamir Law Group
On 31 March 2020, China issued the “Notice Regarding Orderly Development of Medical Goods Exports applicable to the exports of Private Protective Equipment (“PPE”)”, effective 1 April 2020 (the “Notice”). MSI's Taiwan law member Pamir Law Group provides further information.
The Notice is intended to insure the quality of PPE by requiring that Chinese manufacturers of PPE have proper certifications by the State Food and Drug Administration (“SFDA”) and that the manufacturers be listed in the national medical products registry maintained by the SFDA.
The PPE categories covered include the following types of products for fighting coronavirus which require verification:
Special Goods”), and therefore require an Export Health and Quarantine Permit (“EHQP”) issued by the SFDA for export.
The exporter must provide the following documents before shipping to the customs office, which then coordinates with the SFDA officials to verify the contents:
The SFDA will render a decision on the EHQP to the manufacturer within 20 working days.
Download the full article on: New export requirements for ‘PPE’ in China
Read our article in the IAB on how accountants and lawyers are responding to #Covid19 challenges… https://t.co/I7VskpfDJ5
From complete shut-down to great agility: how family courts across the world have responded to Covid-19 https://t.co/uztZwdyfiO
MSI's New Delhi member RNC Legal welcomes new of counsel to its corporate practice https://t.co/VxApZ1saOu #india